Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
52 studies found for:    pancreatic,cancer,detection | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Project Survival-Prospective Biomarker Discovery
Conditions: Pancreatic Neoplasms;   Pancreatic Cancer;   Pancreatitis;   Pancreatic Adenocarcinoma;   Metastatic Pancreatic Cancer
Intervention:
22 Recruiting A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma
Condition: Pancreatic Cancer
Intervention: Drug: TAI-meso-CART
23 Recruiting Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma
Conditions: Neoplastic Cells, Circulating;   Pancreatic Cancer;   Biological Markers
Intervention: Other: No intervention/exposures
24 Recruiting Study of Intratumoral Hypoxia Using Pre-operative Administration of Pimonidazole
Condition: Pancreatic Cancer
Intervention: Drug: Pimonidazole hydrochloride
25 Recruiting Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
Conditions: Pancreatic Cancer;   Metastatic Breast Cancer;   Metastatic Lung Cancer;   Metastatic Colon Cancer;   Metastatic Melanoma;   Metastatic Prostate Cancer
Intervention: Diagnostic Test: NantHealth GPS Cancer Test
26 Recruiting Impact of Margin-accentuation IRE in Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Other: Irreversible electroporation
27 Recruiting Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions
Conditions: Pancreatic Cysts;   Pancreatic Mucinous-Cystic Neoplasm;   Intraductal Papillary Mucinous Neoplasm;   Solid Pseudopapillary Tumour of the Pancreas;   Cystadenocarcinoma;   Serous Cystadenoma
Intervention: Procedure: Endoscopic ultrasound guided needle based confocal endomicroscopy
28 Recruiting A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy
Conditions: Carcinoma, Hepatocellular;   Pancreatic Cancer Metastatic;   Colorectal Cancer Metastatic
Intervention: Drug: CAR-T cell
29 Recruiting Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: Theragene®,Ad5-yCD/mutTKSR39rep-ADP
30 Recruiting Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Conditions: Non-small Cell Lung Cancer;   Esophageal Cancer;   Gastric Cancer;   Pancreatic Cancer;   Hepatocellular Cancer;   Colorectal Cancer
Intervention: Procedure: Study sample collection
31 Not yet recruiting Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma
Condition: Neuroendocrine Tumors
Intervention:
32 Recruiting A Prospective Study To Identify Predictive Biological Markers In Blood And Cyst Fluid Aspirates From Patients With Pancreatic Cyst Lesions
Condition: Pancreatic Cystic Lesions
Intervention: Other: Pancreatic Cyst Aspiration
33 Recruiting Circulating Tumor Cells and Tumor DNA in HCC and NET
Conditions: Carcinoma, Hepatocellular;   Neuroendocrine Tumors
Interventions: Drug: Sorafenib;   Procedure: Radiofrequency ablation (RFA) or surgery;   Drug: Everolimus;   Drug: Lanreotide
34 Recruiting Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Conditions: Colorectal Neoplasms;   Digestive System Diseases;   Colonic Diseases;   Colorectal Cancer
Intervention: Device: Stool Sample Collection Kit
35 Recruiting A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Solid Tumors
Conditions: Metastatic Colorectal Cancer;   Metastatic Renal Cell Carcinoma;   Metastatic Melanoma;   Brain Metastasis;   Locally Advanced or Metastatic Pancreatic Cancer;   Locally Advanced or Metastatic Breast Cancer
Interventions: Biological: Toca 511;   Drug: Toca FC
36 Recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
Conditions: Breast Cancer;   Colon Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastrointestinal Cancer;   Liver and Intrahepatic Biliary Tract Cancer;   Lung Cancer;   Metastatic Cancer;   Pancreatic Cancer;   Rectal Cancer;   Thyroid Gland Medullary Carcinoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: radionuclide imaging;   Procedure: positron emission tomography;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Drug: Cu 64 anti-CEA monoclonal antibody M5A IV
37 Recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Conditions: Endocrine Neoplasms;   Thyroid Neoplasms;   Parathyroid Neoplasms;   Adrenal Neoplasm;   Neuroblastoma
Intervention:
38 Recruiting Nonfunctional Pancreatic NET and PET Imaging
Condition: Diagnosis
Intervention: Device: PET/CT
39 Recruiting Prevalence of Pancreatic Anomalies of Patients With a 1st Degree Familial History of Pancreatic Adenocarcinoma
Condition: Prevalence of Pancreas Adenocarcinomas
Intervention: Procedure: Pancreatic MRI
40 Recruiting Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation With Gemcitabine, Sorafenib and Vorinostat in Resectable, Borderline Resectable or Unresectable Non-metastatic Pancreas Cancer
Conditions: Pancreatic Adenocarcinoma;   Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Pancreatic Cancer;   Stage III Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: Sorafenib;   Drug: Vorinostat;   Radiation: 3-Dimensional Conformal Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Other: RosetteSep;   Other: DEPfff

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-52) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.